EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
Clinical trial NCT03287609 · COMPLETED
Trial details
- NCT number
- NCT03287609
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-23
- Primary completion
- 2019-05-20
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.